FRX™ is led by a world-class team of scientists, driven by the discovery, development, and manufacturing of revolutionary pharmaceuticals. In the United States, bringing biopharmaceuticals to market can be a lengthy and expensive process that is highly regulated by Federal authorities like the Food and Drug Administration. For the medical marijuana industry, unfortunately, this is not the case. Because standardized drug discovery processes to not govern the medical marijuana industries, reproducibility of therapies is virtually impossible. Further, research and discovery becomes unreliable. In an effort to combat this problem, FRX™ has assembled a team of researchers, geneticists, and drug discovery scientists to create reliable, reproducible research studies with medical marijuana.